Clinical Trials
9 trialsNCT05171075 2026-04-17
MAGNOLIA
Anthos Therapeutics, Inc.
Phase 3 Terminated
NCT03297359 2024-01-23
WAVe
Ottawa Hospital Research Institute
Phase 2 Terminated
NCT00041782 2018-10-31
Outpatient Treatment Of Deep Venous Thrombosis Using Subcutaneous Dalteparin (Fragmin) In Low Risk Cancer Patients
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT01817257 2018-10-29
ALICAT
Cardiff University
Phase 2 Terminated
NCT01518465 2017-11-29
Dalteparin, Lenalidomide, and Low-Dose Dexamethasone in Treating Patients With Previously Untreated Multiple Myeloma
University of Southern California
Phase 2 Terminated
NCT00876915 2015-11-24
PHACS
University of Rochester
Phase 3 Terminated
NCT00031837 2015-10-14
Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer
University of Rochester
Phase 3 Terminated
NCT01164046 2014-12-03
Longheva
University Medical Center Groningen
Phase 3 Terminated
NCT00323011 2014-05-21
FOLFIRI + Bevacizumab With or Without Dalteparin in First Line Treatment of Advanced Colorectal Cancer
University of Southern California
Phase 2 Terminated